Expansion, Legalization, Medical, Trending
Aphria Inc. (NYSE: APHA) announced on December 12th that the company has agreed to and signed an official Letter of Intent (LOI) to provide medical cannabis products in Paraguay. Latin American medical cannabis markets can be considered to be in their early stages and...
Cannabis Market, Legalization, Medical
Minnesota’s sales of products that contain cannabidiol (CBD), the non-psychoactive counterpart to tetrahydrocannabinol (THC), have seen continued success in sales as its limited number of retailers struggle to keep shelves stocked. The list of vendors who conduct...
Cannabis Market, Legalization, Medical, Trending
Minnesota’s sales of products that contain cannabidiol (CBD), the non-psychoactive counterpart to tetrahydrocannabinol (THC), have seen continued success in sales as its limited number of retailers struggle to keep shelves stocked. The list of vendors who conduct...
Cannabis Market, Legalization, Medical, Trending
Minnesota’s sales of products that contain cannabidiol (CBD), the non-psychoactive counterpart to tetrahydrocannabinol (THC), have seen continued success in sales as its limited number of retailers struggle to keep shelves stocked. The list of vendors who conduct...
Expansion, Legalization, Medical
Aphria Inc. (NYSE: APHA) announced on December 12th that the company has agreed to and signed an official Letter of Intent (LOI) to provide medical cannabis products in Paraguay. Latin American medical cannabis markets can be considered to be in their early stages and...
Expansion, Legalization, Medical, Trending
Cresco Labs (CSE: CL) announced on December 12th that the company has received the first approval of its kind to operate a medical cannabis dispensary in Ohio. The company’s dispensary is located in Wintersville and offers a range of pharmaceutical-grade medical...
